Insiders

01-14 Novo CEO Sees Strong Demand for Wegovy Obesity Pill MT
01-05 Novo Nordisk's US public affairs head leaves company, memo shows RE
01-05 Obesity drugmaker Novo Nordisk's U.S. public affairs head has left company - memo RE
12-23 Novo Going 'All-In' With Wegovy Weight Loss Pill MT
12-23 Novo CEO Says Wegovy Pill Is Safe and Will Be Widely Available MT
12-23 Novo Nordisk's weight-loss challenge in five charts RE
12-23 PRESS DIGEST- Financial Times - December 23 RE
12-11 Global markets live: Oracle, Waymo, OpenAI, Amazon, Schneider Electric… Zonebourse
12-02 PRESS DIGEST-Canada - Dec 2 RE
12-01 Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound MT
11-25 Novo's Ozempic Pill Fails in Alzheimer's Effort MT
11-24 Novo Nordisk says Alzheimer's drug trial fails, hammering shares RE
11-24 Novo's Ozempic Pill Fails to Slow Alzheimer's in Studies MT
11-17 Hims & Hers names ex-FDA official Deb Autor as first policy chief RE
11-14 Novo Nordisk Elects New Chair, Vice Chair MT
11-14 Novo Nordisk A/S Approves Board Members CI
11-14 Novo Nordisk Shareholders Approve New Chair, Board Members -- Update DJ
11-14 Novo Nordisk Elects New Chair, Vice Chair in Board Shakeup MT
11-14 Novo Nordisk Shareholders Approve New Chair, Board Members DJ
11-14 Novo Nordisk chair touts OTC future for Wegovy as top investor tightens grip RE
11-14 Novo Nordisk Says Mikael Dolsten Won't Seek Election to Board at Friday's Meeting DJ
11-14 Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race RE
11-14 Novo Nordisk A/S Announces Mikael Dolsten Will Not Seek Election as Board of Director CI
11-13 'Not been pretty': Novo Nordisk faces rare shareholder rebuke over board shake-up RE
11-10 Global markets live: Rumble, Tesla, Instacart, Pfizer, Diageo… Zonebourse
No results for this search